Company Data

Cognition Therapeutics Inc.

Ticker
CGTX
Current Price
$0.3238 -0.22%
Market Cap
$20.1M
Price Target
Refer to Report
Volume
356.3K
52wk Range
$0.222301 - $2.535
Advanced Market Data

Overview

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate, CT1812, is an orally delivered, small molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy